Companies: 10,795·Total market cap: $144.5T

Ascletis Pharma Inc.

Ascletis Pharma Inc.

ASCLFOTCHealthcare● Active

$1.35

+$0.03(+2.27%)

Market Cap$1.4B

P/E Ratio—

52W High$2.5

52W Low$0.9325

Avg Volume679

Open$1.35

Beta0.40

Net Income Financials Revenue

Ascletis Pharma Inc. (ASCLF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ASCLF · net income · updated Jun 9, 2026

Core profitability metrics

ASCLF · net income · margin · TTM · CAGR

Net income was −$350.6M for FY2025 (fiscal year ending 2025-12-31), down 16.5% year-over-year. Net profit margin was -17745.6%.

FY2025 Net Income−$350.6M▼ -16.5% YoY

Trailing 12M (TTM)−$656.3Mtrailing 4 quarters sum

Net Profit Margin< −999%−$350.6M ÷ $2.0M

YoY Change-16.5%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · ASCLF net income history · ASCLF profit margin

Annual net income data

ASCLF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$350.6M▼ 16.5%-17745.6%$2.0M

FY2024Loss−$300.9M▼ 108.0%-23455.7%$1.3M

FY2023Loss−$144.7M▲ +54.0%-255.7%$56.6M

FY2022Loss−$314.8M▼ 58.2%-582.1%$54.1M

FY2021Loss−$199.0M▲ +4.9%-258.9%$76.9M

Net income vs peers (Healthcare)

ASCLF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Ascletis Pharma Inc.YOU

ASCLF

−$350.6M-16.5%-17745.6%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Ascletis Pharma Inc. (ASCLF) reported net income of −$350.6M for FY2025 (fiscal year ending 2025-12-31), down 16.5% year-over-year. The net profit margin was -17745.6% — meaning the company kept $-177.46 of every dollar of revenue as profit.

Ascletis Pharma Inc. has not yet achieved annual profitability based on available data (10 fiscal years). The company has reported net losses across all available periods.

Ascletis Pharma Inc.'s net profit margin was -17745.6% for FY2025, based on the latest annual results.

Investors sometimes search for "Ascletis Pharma Inc. net worth" — the company's market capitalization is a separate figure from ASCLF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ASCLF net income · 4 questions

Ascletis Pharma Inc. is not currently profitable on an annual basis. The company reported a net loss of $350.6M for FY2025.

is ASCLF profitabledoes ASCLF make a profitASCLF profitabilityASCLF profitable company

▸ Source: FMP /income-statement · GAAP · Ascletis Pharma Inc. · Ascletis Pharma Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026